NIH-funded research NIH-funded research

Exploring gene mutations linked to skin conditions in Latinx patients

Official title: Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis

Funded at University of Pennsylvania · NIH-10909292 · Data updated 2026-11-12

This study is looking at how certain gene changes might affect the severity of atopic dermatitis in Latinx patients, with the hope of improving how we diagnose and manage this skin condition.

More Atopic Dermatitis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 17, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$172,709
NIH project number5K23AR081984-02
Project IDNIH-10909292 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are Latinx individuals diagnosed with atopic dermatitis, particularly those experiencing severe symptoms.

Less likely to help

Patients who do not have atopic dermatitis or those from non-Latinx backgrounds may not benefit from this research.

What this research studies

This research investigates the role of specific gene mutations in the development of atopic dermatitis among Latinx patients. By examining the filaggrin gene, which is known to affect skin barrier function, the study aims to understand how genetic variations and ancestry contribute to the severity of this chronic skin condition. The research will involve collecting genetic data from participants and analyzing how these factors interact with environmental influences. Ultimately, the goal is to enhance diagnostic and management strategies for atopic dermatitis in this population.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and management strategies for atopic dermatitis in Latinx patients.

How similar studies have gone: Previous research has shown promising results in understanding genetic factors in atopic dermatitis, but this specific focus on Latinx populations is relatively novel.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Chiesa Fuxench, Zelma Charlotte — University of Pennsylvania
  • Study coordinator: Chiesa Fuxench, Zelma Charlotte

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.